HU 331

• Description:

  HU 331 (HU 331) is a highly specific Topoisomerase II inhibitor with anticancer activity. HU 331 has shown promising inhibitory effects on human cancer cell lines in vitro and human tumor xenografts in nude mice in vivo[1].

• Product Name Alternative:

  VCE 004

• UNSPSC:

  12352211

• Hazard Statement:

  H302-H361

• Target:

  Topoisomerase

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/hu-331.html

• Smiles:

  CC([C@H]1[C@H](C2=C(C(C(CCCCC)=CC2=O)=O)O)C=C(CC1)C)=C

• Molecular Formula:

  C21H28O3

• Molecular Weight:

  328.45

• Precautions:

  P264-P270-P280-P330-P405-P501

• References & Citations:

  [1]Kogan N M, et al. HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor[J]. Molecular Cancer Therapeutics, 2007, 6 (1) : 173-183.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  Topo II

• CAS Number:

  [137252-25-6]